Vascular Endothelial Growth Factor Antibodies Market

Vascular Endothelial Growth Factor Antibodies Market contains market size and forecasts of Vascular Endothelial Growth Factor (VEGF) Antibodies in global, including the following market information:

Global Vascular Endothelial Growth Factor (VEGF) Antibodies Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Vascular Endothelial Growth Factor (VEGF) Antibodies Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Vascular Endothelial Growth Factor (VEGF) Antibodies companies in 2021 (%)

The global Vascular Endothelial Growth Factor (VEGF) Antibodies market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Bevacizumab Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Vascular Endothelial Growth Factor (VEGF) Antibodies include Roche, Novartis, Sanofi, Regeneron, Bayer, AstraZeneca, Pfizer, Merck and Eli Lilly, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Vascular Endothelial Growth Factor (VEGF) Antibodies manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Vascular Endothelial Growth Factor (VEGF) Antibodies Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Vascular Endothelial Growth Factor (VEGF) Antibodies Market Segment Percentages, by Type, 2021 (%)

Bevacizumab

Ranibizumab

Aflibercept

Others

Global Vascular Endothelial Growth Factor (VEGF) Antibodies Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Vascular Endothelial Growth Factor (VEGF) Antibodies Market Segment Percentages, by Application, 2021 (%)

Hospitals

Specialty Clinics

Ambulatory Surgical Centers

Cancer Research Institutes

Others

Global Vascular Endothelial Growth Factor (VEGF) Antibodies Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Vascular Endothelial Growth Factor (VEGF) Antibodies Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Vascular Endothelial Growth Factor (VEGF) Antibodies revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Vascular Endothelial Growth Factor (VEGF) Antibodies revenues share in global market, 2021 (%)

Key companies Vascular Endothelial Growth Factor (VEGF) Antibodies sales in global market, 2017-2022 (Estimated), (K Units)

Key companies Vascular Endothelial Growth Factor (VEGF) Antibodies sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

Roche

Novartis

Sanofi

Regeneron

Bayer

AstraZeneca

Pfizer

Merck

Eli Lilly

GlaxoSmithKline

Bristol-Myer Squibb

Boehringer Ingelheim

Abcam Plc